Does ELTROMBOPAG OLAMINE Cause Red cell distribution width increased? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Red cell distribution width increased have been filed in association with ELTROMBOPAG OLAMINE (ELTROMBOPAG). This represents 0.1% of all adverse event reports for ELTROMBOPAG OLAMINE.
12
Reports of Red cell distribution width increased with ELTROMBOPAG OLAMINE
0.1%
of all ELTROMBOPAG OLAMINE reports
5
Deaths
9
Hospitalizations
How Dangerous Is Red cell distribution width increased From ELTROMBOPAG OLAMINE?
Of the 12 reports, 5 (41.7%) resulted in death, 9 (75.0%) required hospitalization, and 1 (8.3%) were considered life-threatening.
Is Red cell distribution width increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ELTROMBOPAG OLAMINE. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does ELTROMBOPAG OLAMINE Cause?
Platelet count decreased (3,419)
Death (2,797)
Drug ineffective (1,117)
Platelet count increased (980)
Fatigue (868)
Headache (750)
Nausea (584)
Diarrhoea (558)
Product use in unapproved indication (545)
Malaise (516)
What Other Drugs Cause Red cell distribution width increased?
CLOZAPINE (439)
METHOTREXATE (210)
ALEMTUZUMAB (202)
RITUXIMAB (198)
PREDNISONE (178)
PALBOCICLIB (171)
ADALIMUMAB (144)
METHYLPREDNISOLONE (123)
ECULIZUMAB (110)
TOCILIZUMAB (108)
Which ELTROMBOPAG OLAMINE Alternatives Have Lower Red cell distribution width increased Risk?
ELTROMBOPAG OLAMINE vs ELUXADOLINE
ELTROMBOPAG OLAMINE vs ELVITEGRAVIR
ELTROMBOPAG OLAMINE vs EMAPALUMAB
ELTROMBOPAG OLAMINE vs EMAPALUMAB-LZSG
ELTROMBOPAG OLAMINE vs EMEND